Agilus Diagnostics has installed the Illumina NovaSeq X platform, marking an important technological addition as it continues to strengthen its digital and technology capabilities. Led by MD & CEO Dr Anand K, this initiative will lead the precision genomics function, driving high-throughput sequencing initiatives, strengthening multi-omic analysis platforms, and enabling scalable, secure, and future-ready operations aligned with business objectives across India’s healthcare sector.

The rollout reflects the firm’s focus on leveraging technology as a key enabler of operational excellence, efficiency, and innovation. This platform will play a critical role in spearheading personalized medicine, enhancing digital resilience, and supporting cross-functional teams with robust technology solutions across the global enterprise.

Dr. Anand brings over 25 years of leadership experience from organizations including Metropolis Healthcare, Neuberg Diagnostics, and Apollo Health and Lifestyle. His journey positions the group to build a strong foundation for long-term organizational success.